Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Vangu
nuclear medicine, Johannesburg, South Africa
nuclear medicine, Johannesburg, South Africa
What are the opportunities brought by the BCU and what are the contributions of genetics to the management of breast cancer?
Pascal PUJOL
Chairman of the Genetic department, University Hospital, Montpellier, France
Ultrasound-guided breast ablation
Yijie DONG
Management of bone metastasis in the spine.
Nicolas AMORETTI
Radiologist, Nice, France
AI Applications in Breast Cancer Diagnosis and Treatment
Isabelle THOMASSIN-NAGGARA